In March 2025, the company introduced new plans for a immediate-to-shopper offering of its Wegovy weight loss drug. The company established a whole new pharmacy, identified as NovoCare, which might cost buyers $499 a month for usage of the drug, less than 50 % the price of the drug through other pharmaceutical distribution networks.[fifty three]On